Skip to main content
Caplight Logo









omni:us

omni:us

Private
BerlinFinTechhttps://omnius.com/

Last Round

Series A

Extension

Nov 15, 2022

Total Funding Raised

$27.11M

Company Overview

omni:us is an insurance technology company that provides an AI-powered platform for end-to-end automation of insurance claims.

Sector

FinTech

Verticals

InsurTech, NLP & Conversational AI, Document Management, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

claims automationinsurtechAI claims processingdocument automationAIaaSclaims managementintelligent document processingIDPFNOL automationclaims adjuster co-pilotinsurance AIworkflow automationSaaS insurance platformclaims leakage detectionstraight-through processingSTPclaims tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

omni:us Comparables

Compare omni:us with similar companies based on industry and business-model similarity.

omni:us comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sprout.ai
91%
Claimsforce
83%
MarvelX
81%

omni:us Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionNov 15, 2022
Series A ExtensionFeb 27, 2020
GrantSep 27, 2019
Series AOct 30, 2018

Key People

Founding team and executive leadership

Martin Micko

COO Founder

Founding Team

Thomas Hauschild

Chief Executive Officer

Executive Team

omni:us Investors

Notable investors and investment history

omni:us investors
InvestorRounds
European Innovation Council FundGrant
European CommissionGrant
CommerzVenturesSeries A Extension
Baloise Strategic VenturesSeries A
Target GlobalSeries A Extension, Series A
UNIQA VenturesSeries A Extension
AnthemisSeed, Series A, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 27, 2020

    $13M round led by CommerzVentures and Viola Group.

omni:us Filings

Explore SEC and related filing metadata, where available.

omni:us filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about omni:us's valuation, stock price, and market status.

Is omni:us a public or private company?

omni:us is a private company.

What is the current stock price of omni:us?

omni:us is a private company with no public stock price. No recent secondary market data is available.

How much is omni:us worth (valuation)?

Valuation information for omni:us is not publicly available.

Can I buy omni:us stock?

omni:us shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was omni:us's last funding round?

omni:us's most recent funding round was Series A Extension on November 15, 2022.

Who are the main investors in omni:us?

Key investors in omni:us include CommerzVentures, Target Global, Viola Group.

Will omni:us IPO soon?

No public IPO plans have been announced for omni:us.

How can I track omni:us secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor omni:us's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerlin
Employee Range45
Year Founded2015
Last FundingNov 15, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?